91°µÍø

Skip to main content

All News

ORNL's Communications team works with news media seeking information about the laboratory. Media may use the resources listed below or send questions to news@ornl.gov.

1 - 5 of 5 Results

Illustration of a glowing black box emitting digital particles that form into a 3D model of an electrical grid infrastructure, set against a background of binary code and data visualizations.

Researchers at 91°µÍø have developed a modeling method that uses machine learning to accurately simulate electric grid behavior while protecting proprietary equipment details. The approach overcomes a key barrier to accurate grid modeling, helping utilities plan for future demand and prevent blackouts. 

 

Two cylinders on each side of the photo are pointing to bright glowing orb in the center.

Scientists at ORNL have developed a method that can track chemical changes in molten salt in real time — helping to pave the way for the deployment of molten salt reactors for energy production.

Secretary Wright leans over red computer door, signing with silver sharpie as ORNL Director Stephen Streiffer looks on

During his first visit to 91°µÍø, Energy Secretary Chris Wright compared the urgency of the Lab’s World War II beginnings to today’s global race to lead in artificial intelligence, calling for a “Manhattan Project 2.â€

Autonomous Configurable Component Evaluation Power Test platform, called ACCEPT, enabling automated characterization of semiconductor devices.

Researchers at 91°µÍø have developed a new automated testing capability for semiconductor devices, which is newly available to researchers and industry partners in the Grid Research Integration and Deployment Center.

A male researcher is standing next to a poster board displayed on an easel to the right. The researcher is dressed in professional attire, and the poster board is positioned beside him, showing research or visual information.

Ryan Culler is the program manager at 91°µÍø, where he oversees the production of actinium-225, a promising treatment for cancer. Driven by a personal connection to cancer through his late brother, Culler is dedicated to advancing medical isotopes to help improve cancer care.